Evidence map›Paper›PMID 40632493›Full record

Observational studyNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association2025

Risk-based referral model to nephrologist specialist care in Stockholm.

Aurora Caldinelli, Anne-Laure Faucon, Arvid Sjölander, Roosa Lankinen, Antoine Creon, Edouard L Fu, Marie Evans, Juan Jesus Carrero

Abstract readObservational Study
In one paragraph

Observational study in Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Aurora CaldinelliDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.ORCID 0009-0009-6019-9342
Anne-Laure FauconDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0001-6716-1157
Arvid SjölanderDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Roosa LankinenDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Antoine CreonDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.ORCID 0009-0006-6498-0257
Edouard L FuDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0002-9698-6825
Marie EvansRenal Medicine, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Karolinska Hospital, Stockholm, Sweden.ORCID 0000-0001-8650-5795
Juan Jesus CarreroDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0003-4763-2024

Funding

Medication Use and Adverse Events in CKDR01DK115534 · NIDDK · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Alexander R Chang, Morgan Erika Grams · 2018 to 2026
$5.7M
NIDDK NIH HHS R01 DK115534Region Stockholm FoUI-986028Swedish Heart and Lung Foundation 20230371Swedish Research Council 2023-01807US National Institutes of Health R01DK115534
6 · The paper itself

Abstract

backgroundFor most patients, clinical management of the early stages of chronic kidney disease is performed in primary care settings. The Kidney Disease: Improving Global Outcomes (KDIGO) 2024 guidelines recommend using a 5-year kidney failure risk equation (KFRE) of 3-5% to guide nephrologist referrals. Here, we aimed to assess the impact of adopting a risk-based referral model compared with traditional referral criteria.

methodsWe conducted an observational retrospective study of adults with an estimated glomerular filtration rate (eGFR) <60 ml/min/1.73 m2 (Lund-Malmö equation) from the SCREAM project, a healthcare utilization cohort from Stockholm, Sweden. We evaluated the performance of the non-North American four-variable KFRE and recalibrated it to better fit our setting. KFRE thresholds were compared with traditional models-the clinical Swedish criteria and the classic KDIGO 2012 criteria-both of which are mainly based on age, eGFR and albuminuria thresholds. Sensitivity, specificity, positive and negative predictive values, reclassification matrices, net reclassification improvement and decision curve analyses were used to assess performance and clinical utility.

resultsThe study included 887 388 observations from 192 964 individuals. At inclusion, 49% were men, median age was 76 years and median eGFR was 54 ml/min/1.73 m2. During follow-up, 2624 (1.4%) progressed to KRT. The KFRE demonstrated good prediction performance, which further improved after recalibration. Both the non-North American- and SCREAM-recalibrated KFRE provided higher sensitivity and specificity than Swedish and classical KDIGO criteria. KFRE-based referral models yielded better net reclassification improvement, demonstrating superior performance in decision curve analyses. Higher thresholds (15% for the non-North American-recalibrated KFRE, 9% for the SCREAM-recalibrated KFRE) than the KDIGO recommended ones provided the best combined sensitivity and specificity. Compared with traditional referral models, implementation of a risk-based referral would decrease the number of unnecessary referrals by 23% and 25%, respectively.

conclusionIn a large northern European healthcare system, transitioning to a risk-based referral model would result in an important reduction in unnecessary referrals while maintaining a low rate of missed cases, optimizing resource utilization.

Indexed as

NephrologistsNephrologyReferral and ConsultationRenal Insufficiency, ChronicAgedFemaleFollow-Up StudiesGlomerular Filtration RateHumansMaleMiddle AgedPrognosisRetrospective StudiesRisk AssessmentRisk FactorsSwedenkidney diseasekidney failure risk equationnephrology referral

Identifiers

PMID40632493
PMCPMC12722175

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.